"Designing Growth Strategies is in our DNA"

Immune Thrombocytopenia (ITP) Market Size, Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026

Region : Global | Format: PDF | Report ID: FBI101682

 

Table of Content:

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Immune Thrombocytopenia for Key Countries, 2018
    2. Introduction of New Products / Approvals (by Major Players)
    3. Recent Developments Mergers, Acquisitions and Partnerships
    4. Pipeline Analysis
    5. Patent Analysis
  5. Global Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis, Insights and Forecast – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country
      1. U.S.
      2. Canada
  7. U.S. Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  8. Canada Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  9. Europe Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Rest of Europe
  10. Germany Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  11. France Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  12. U.K. Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  13. Italy Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  14. Spain Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  15. Rest of Europe Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  16. Asia Pacific Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
    5. Market Analysis – By Country
      1. Japan
      2. China
      3. India
      4. South Korea
      5. Australia
      6. Rest of Asia Pacific
  17. Japan Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  18. China Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  19. India Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  20. South Korea Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  21. Australia Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  22. Rest of Asia Pacific Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  23. Latin America Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  24. Middle East & Africa Immune Thrombocytopenia Market Analysis, Insights and Forecast, 2015-2026
    1. Key Findings / Summary
    2. Market Analysis – By Type
      1. Acute Immune Thrombocytopenia
      2. Chronic Immune Thrombocytopenia
    3. Market Analysis – By Treatment
      1. Thrombopoietin Receptor Agonists
      2. Immunoglobulins
      3. Corticosteroids
      4. Others
    4. Market Analysis – By Distribution Channel
      1. Hospital Pharmacy
      2. Retail Pharmacy
      3. Others
  25. Competitive Analysis
    1. Global Market Share Analysis (2018)
    2. Company Profiles (Overview, Products & services, SWOT analysis, Recent developments, strategies, financials (based on availability))
      1. Amgen Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      2. Novartis AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      3. Rigel Pharmaceuticals, Inc.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      4. Dova Pharmaceuticals
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      5. Grifols S.A
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      6. CSL Limited
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      7. Octapharma AG
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      8. Intas Pharmaceuticals Ltd.
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)
      9. Saol Therapeutics
        1. Overview,
        2. Products & services,
        3. SWOT analysis,
        4. Recent developments,
        5. strategies,
        6. financials (based on availability)

 

List of Figures

Figure 01: Global Immune Thrombocytopenia Market Revenue Breakdown (US$ Mn, %) by Region, 2018 & 2026

Figure 02: Global Immune Thrombocytopenia Market Value Share (%), by Type, 2018 & 2026

Figure 03: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Acute Immune thrombocytopenia, 2015–2026

Figure 04: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Chronic Immune thrombocytopenia, 2015–2026

Figure 05: Global Immune Thrombocytopenia Market Value Share (%), By Treatment, 2018 & 2026

Figure 06: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Thrombopoietin Receptor Agonists, 2015–2026

Figure 07: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Immunoglobulins, 2015–2026

Figure 08: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Corticosteroids, 2015–2026

Figure 09: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Others, 2015–2026

Figure 10: Global Immune Thrombocytopenia Market Value Share (%), By Distribution Channel, 2018 & 2026

Figure 11: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Hospital Pharmacy, 2015–2026

Figure 12: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Retail Pharmacy, 2015–2026

Figure 13: Global Immune Thrombocytopenia Market Forecast (US$ Mn), by Others, 2015–2026

Figure 14: Global Immune Thrombocytopenia Market Value (US$ Mn), by Region, 2018 & 2026

Figure 15: North America Immune Thrombocytopenia Market Value (US$ Mn), By Type, 2018 & 2026

Figure 16: North America Immune Thrombocytopenia Market Value Share (%), By Type, 2018

Figure 17: North America Immune Thrombocytopenia Market Value (US$ Mn), By Treatment, 2018 & 2026

Figure 18: North America Immune Thrombocytopenia Market Value Share (%), By Treatment, 2018

Figure 19: North America Immune Thrombocytopenia Market Value (US$ Mn), By Distribution Channel, 2018 & 2026

Figure 20: North America Immune Thrombocytopenia Market Value Share (%), By Distribution Channel, 2018

Figure 21: North America Immune Thrombocytopenia Market Value (US$ Mn), by Country, 2018 & 2025

Figure 22: North America Immune Thrombocytopenia Market Value Share (%), by Country, 2018

Figure 23: U.S. Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 24: U.S. Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 25: U.S. Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 26: Canada Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 27: Canada Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 28: Canada Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 29: Europe Immune Thrombocytopenia Market Value (US$ Mn), By Type, 2018 & 2026

Figure 30: Europe Immune Thrombocytopenia Market Value Share (%), By Type, 2018

Figure 31: Europe Immune Thrombocytopenia Market Value (US$ Mn), By Treatment, 2018 & 2026

Figure 32: Europe Immune Thrombocytopenia Market Value Share (%), By Treatment, 2018

Figure 33: Europe Immune Thrombocytopenia Market Value (US$ Mn), By Distribution Channel, 2018 & 2026

Figure 34: Europe Immune Thrombocytopenia Market Value Share (%), By Distribution Channel, 2018

Figure 35: Europe Immune Thrombocytopenia Market Value (US$ Mn), by Country, 2018 & 2026

Figure 36: Europe Immune Thrombocytopenia Market Value Share (%), by Country, 2018

Figure 37: Germany Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 38: Germany Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 39: Germany Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 40: France Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 41: France Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 42: France Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 43: U.K. Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 44: U.K. Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 45: U.K. Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 46: Italy Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 47: Italy Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 48: Italy Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 49: Spain Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 50: Spain Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 51: Spain Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 52: Rest of Europe Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 53: Rest of Europe Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 54: Rest of Europe Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 55: Asia Pacific Immune Thrombocytopenia Market Value (US$ Mn), By Type, 2018 & 2026

Figure 56: Asia Pacific Immune Thrombocytopenia Market Value Share (%), By Type, 2018

Figure 57: Asia Pacific Immune Thrombocytopenia Market Value (US$ Mn), By Treatment, 2018 & 2026

Figure 58: Asia Pacific Immune Thrombocytopenia Market Value Share (%), By Treatment, 2018

Figure 59: Asia Pacific Immune Thrombocytopenia Market Value (US$ Mn), By Distribution Channel, 2018 & 2026

Figure 60: Asia Pacific Immune Thrombocytopenia Market Value Share (%), By Distribution Channel, 2018

Figure 61: Asia Pacific Immune Thrombocytopenia Market Value (US$ Mn), by Country, 2018 & 2026

Figure 62: Asia Pacific Immune Thrombocytopenia Market Value Share (%), by Country, 2018

Figure 63: Japan Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 64: Japan Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 65: Japan Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 66: China Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 67: China Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 68: China Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 69: India Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 70: India Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 71: India Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 72: South Korea Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 73: South Korea Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 74: South Korea Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 75: Australia Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 76: Australia Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 77: Australia Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 78: Rest of Asia Pacific Immune Thrombocytopenia Value Share (%), by Type, 2018

Figure 79: Rest of Asia Pacific Immune Thrombocytopenia Value Share (%), by Treatment, 2018

Figure 80: Rest of Asia Pacific Immune Thrombocytopenia Value Share (%), by Distribution Channel, 2018

Figure 81: Latin America Immune Thrombocytopenia Market Value (US$ Mn), By Type, 2018 & 2026

Figure 82: Latin America Immune Thrombocytopenia Market Value Share (%), By Type, 2018

Figure 83: Latin America Immune Thrombocytopenia Market Value (US$ Mn), By Treatment, 2018 & 2026

Figure 84: Latin America Immune Thrombocytopenia Market Value Share (%), By Treatment, 2018

Figure 85: Latin America Immune Thrombocytopenia Market Value (US$ Mn), By Distribution Channel, 2018 & 2026

Figure 86: Latin America Immune Thrombocytopenia Market Value Share (%), By Distribution Channel, 2018

Figure 87: Middle East & Africa Immune Thrombocytopenia Market Value (US$ Mn), By Type, 2018 & 2026

Figure 88: Middle East & Africa Immune Thrombocytopenia Market Value Share (%), By Type, 2018

Figure 89: Middle East & Africa Immune Thrombocytopenia Market Value (US$ Mn), By Treatment, 2018 & 2026

Figure 90: Middle East & Africa Immune Thrombocytopenia Market Value Share (%), By Treatment, 2018

Figure 91: Middle East & Africa Immune Thrombocytopenia Market Value (US$ Mn), By Distribution Channel, 2018 & 2026

Figure 92: Middle East & Africa Immune Thrombocytopenia Market Value Share (%), By Distribution Channel, 2018

Figure 93: Global Immune Thrombocytopenia Market Share Analysis (%), By Company, 2018

 

List of Tables

Table 01: Global Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 02: Global Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Treatment, 2015–2026

Table 03: Global Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Distribution Channel, 2015–2026

Table 04: Global Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, by Region, 2015–2026

Table 05: North America Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Type, 2015–2026

Table 06: North America Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Treatment, 2015–2026

Table 07: North America Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Distribution Channel, 2015–2026

Table 08: North America Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, by Country, 2015–2026

Table 09: U.S. Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 10: U.S. Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 11: U.S. Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 12: Canada Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 13: Canada Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 14: Canada Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 15: Europe Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Type, 2015–2026

Table 16: Europe Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Treatment, 2015–2026

Table 17: Europe Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Distribution Channel, 2015–2026

Table 18: Europe Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015–2026

Table 19: Germany Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 20: Germany Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 21: Germany Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 22: France Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 23: France Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 24: France Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 25: U.K. Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 26: U.K. Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 27: U.K. Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 28: Italy Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 29: Italy Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 30: Italy Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 31: Spain Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 32: Spain Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 33: Spain Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 34: Rest of Europe Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 35: Rest of Europe Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 36: Rest of Europe Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 37: Asia Pacific Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Type, 2015–2026

Table 38: Asia Pacific Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Treatment, 2015–2026

Table 39: Asia Pacific Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Distribution Channel, 2015–2026

Table 40: Asia Pacific Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2015–2026

Table 41: Japan Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 42: Japan Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 43: Japan Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 44: China Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 45: China Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 46: China Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 47: India Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 48: India Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 49: India Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 50: South Korea Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 51: South Korea Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 52: South Korea Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 53: Australia Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 54: Australia Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 55: Australia Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 56: Rest of Asia Pacific Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Type, 2015–2026

Table 57: Rest of Asia Pacific Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Treatment, 2015–2026

Table 58: Rest of Asia Pacific Immune Thrombocytopenia Revenue (US$ Mn) Forecast, by Distribution Channel, 2015–2026

Table 59: Latin America Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Type, 2015–2026

Table 60: Latin America Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Treatment, 2015–2026

Table 61: Latin America Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Distribution Channel, 2015–2026

Table 62: Middle East & Africa Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Type, 2015–2026

Table 63: Middle East & Africa Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Treatment, 2015–2026

Table 64: Middle East & Africa Immune Thrombocytopenia Market Revenue (US$ Mn) Forecast, By Distribution Channel, 2015–2026

 class=
  • Nov, 2019
  • 2018
  • 2015-2017
  • 212

    CHOOSE LICENSE TYPE

  • 4850
    6850
    8850

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.
X